KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 9, 2005, Pages 5432-5440

  Stathatos, Nikolaos ^a,b   Bourdeau, Isabelle ^c   Espinosa, Allan V ^a   Saji, Motoyasu ^a   Vasko, Vasily V ^a,b,c   Burman, Kenneth D ^b   Stratakis, Constantine A ^d   Ringel, Matthew D ^a,b,c,e  

^a OHIO STATE UNIVERSITY   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CYCLOSPORIN A; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 54; METASTIN; MITOGEN ACTIVATED PROTEIN KINASE; MYOCYTE ENRICHED CALCINEURIN INTERACTING PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE C; RECEPTOR SUBTYPE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL MIGRATION; DNA MICROARRAY; EXPERIMENTAL MODEL; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; NULL ALLELE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; THYROID CANCER; THYROID PAPILLARY CARCINOMA; WESTERN BLOTTING;

CALCINEURIN; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCLE PROTEINS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; THYROID NEOPLASMS; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 24344448213     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-0963     Document Type: Article

References (36)

1. Shevde LA, Welch DR 2003 Metastasis suppressor pathways: an evolving paradigm. Cancer Lett 198:1-20
2. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR 1996 KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 88:1731-1737
3. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brezillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C, Schiffmann SN, Vassart G, Parmentier M 2001 The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 276:34631-34636
4. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, Ishibashi Y, Watanabe T, Asada M, Yamada T, Suenaga M, Kitada C, Usuki S, Kurokawa T, Onda H, Nishimura O, Fujino M 2001 Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411:613-617
5. Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM, Chambers JK, Murdock P, Steplewski K, Shabon U, Miller JE, Middleton SE, Darker JG, Larminie CG, Wilson S, Bergsma DJ, Emson P, Faull R, Philpott KL, Harrison DC 2001 AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 276:28969-28975
6. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E 2003 Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA100:10972-10976
7. Funes S, Hedrick JA, Vassileva, G, Markowitz L, Abbondanzo S, Golovko A, Yang S, Monsma FJ, Gustafson EL 2003 The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system. Biochem Biophys Res Commun 312:1357-1363
8. Ikeguchi M, Yamaguchi K, Kaibara N 2004 Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. Clin Cancer Res 10:1379-1383
9. Masui T, Doi R, Mori T, Toyoda E, Koizumi M, Kami K, Ito D, Peiper SC, Broach JR, Oishi S, Niida A, Fujii N, Imamura M 2004 Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun 315:85-92
10. Sanchez-Carbayo M, Capodieci P, Cordon-Cardo C 2003 Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. Am J Pathol 162:609-617
11. Shirasaki F, Takata M, Hatta N, Takehara K 2001 Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. Cancer Res 61:7422-7425
12. Ikeguchi M, Hirooka Y, Kaibara N 2003 Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma. J Cancer Res Clin Oncol 129:531-535
13. Ringel MD, Hardy E, Bernet VJ, Burch HB, Schuppert F, Burman KD, Saji M 2002 Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab 87:2399
14. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP 2001 Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 22:631-656
15. Fagin JA 2002 Branded from the start: distinct oncogenic initiating events may determine tumor fate in the thyroid. Mol Endocrinol 16:903-911
16. Rothermel BA, Vega RB, Williams RS 2003 The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc Med 13:15-21
17. Vasko V, Saji M, Hardy E, Kruhlak M, Larin A, Savchenko V, Miyakawa M, Isozaki O, Murakami H, Tsushima T, Burman KD, De Micco C, Ringel MD 2004 Akt activation and localization correlate with tumor invasion and oncogene expression in thyroid cancer. J Mol Genet 41:161-170
18. Braga-Basaria M, Hardy E, Gottfried R, Burman KD, Saji M, Ringel MD 2004 17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels. J Clin Endocrinol Metab 89:2982-2988
19. Bourdeau I, Antonini SR, Lacroix A, Kirschner LS, Matyakhina L, Lorang D, Libutti SK, Stratakis CA 2004 Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene 23:1575-1585
20. Du K, Herzig S, Kulkarni RN, Montminy M 2003 TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300:1574-1577
21. Ringel MD, Hayre N, Saito J, Saunier B, Schuppert F, Burch H, Bernet V, Burman KD, Kohn LD, Saji M 2001 Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res 61:6105-6111
22. Macian F, Garcia-Cozar F, Im SH, Horton HF, Byrne MC, Rao A 2002 Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109:719-731
23. Fuentes JJ, Genesca L, Kingsbury TJ, Cunningham KW, Perez-Riba M, Estivill X, de la Luna S 2000 DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9:1681-1690
24. Hanahan D, Weinberg RA 2000 The hallmarks of cancer. Cell 100:57-70
25. Friedl P, Wolf K 2003 Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3:362-374
26. Meehan WJ, Welch DR 2003 Breast cancer metastasis suppressor 1: update. Clin Exp Metastasis 20:45-50
27. Steeg PS 2003 Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 3:55-63
28. Arai T, Watanabe M, Onodera M, Yamashita T, Masunaga A, Itoyama S, Itoh K, Sugawara I 1993 Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid. Am J Pathol 142:1938-1944
29. Brabant G, Hoang-Vu C, Cetin Y, Dralle H, Scheumann G, Molne J, Hansson G, Jansson S, Ericson LE, Nilsson M 1993 E-cadherin: a differentiation marker in thyroid malignancies. Cancer Res 53:4987-4993
30. Ito Y, Yoshida H, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma K, Miyauchi A 2003 KAI1 expression in thyroid neoplasms: its linkage with clinicopathologic features in papillary carcinoma. Pathol Res Pract 199:79-83
31. Martin B, Pallen CJ, Wang JH, Graves DJ 1985 Use of fluorinated tyrosine phosphates to probe the substrate specificity of the low molecular weight phosphatase activity of calcineurin. J Biol Chem 260:14932-14937
32. Vega RB, Yang J, Rothermel BA, Bassel-Duby R, Williams RS 2002 Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J Biol Chem 277:30401-30407
33. Minami T, Horiuchi K, Miura M, Abid MR, Takabe W, Noguchi N, Kohro T, Ge X, Aburatani H, Hamakubo T, Kodama T, Aird WC 2004 Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 279:50537-50554
34. Iizuki M, Abe M, Shiiba K, Sasaki I, Sato Y 2004 Down syndrome candidate region 1, a downstream target of VEGF, participates in endothelial cell migration and angiogenesis. J Vasc Res 41:334-344
35. Hampton T 2005 Down syndrome protein deters cancer: scientists reveal molecular mechanism. JAMA 293:284-285
36. Penn I 1999 Posttransplant malignancies. Transplant Proc 31:1260-1262